Jei Kim Selected Research

Toothpastes

12/2020

Bleaching toothpaste with two different concentrations of hydrogen peroxide: A randomized double-blinded clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jei Kim Research Topics

Disease

12	Stroke (Strokes) 01/2022 - 06/2008
7	Ischemic Stroke 01/2022 - 04/2014
4	Atherosclerosis 01/2023 - 01/2007
4	Neoplasms (Cancer) 01/2015 - 07/2009
2	Hypertension (High Blood Pressure) 01/2023 - 01/2018
2	Pathologic Constriction (Stenosis) 01/2023 - 01/2017
2	Thrombosis (Thrombus) 04/2013 - 11/2006
2	Cerebral Infarction 04/2013 - 06/2008
2	Colonic Neoplasms (Colon Cancer) 07/2009 - 07/2009
2	Hepatocellular Carcinoma (Hepatoma) 07/2009 - 07/2009
2	Stomach Neoplasms (Stomach Cancer) 07/2009 - 07/2009
2	Venous Thrombosis (Deep-Vein Thrombosis) 11/2006 - 10/2005
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2022
1	Atrial Fibrillation 01/2022
1	Contact Dermatitis (Eczema, Contact) 12/2020
1	Delirium 11/2019
1	Cognitive Dysfunction 05/2018
1	Embolic Stroke 01/2018
1	Patent Foramen Ovale 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2017
1	Constipation 01/2017
1	Myalgia 01/2017
1	Adenocarcinoma of Lung 06/2015
1	Hyperplasia 06/2015
1	Adenocarcinoma in Situ 06/2015
1	Kidney Neoplasms (Kidney Cancer) 01/2015
1	Hemorrhage 04/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2012
1	Cerebellar Diseases (Cerebellar Syndrome) 12/2006
1	Retinal Vein Occlusion 11/2006
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 10/2005

Drug/Important Bio-Agent (IBA)

5	Escitalopram FDA Link 11/2021 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 07/2009
2	Lipoprotein(a)IBA 01/2023 - 01/2017
2	Serotonin (5 Hydroxytryptamine)IBA 11/2021 - 01/2018
2	Sunitinib (Sutent)FDA Link 01/2015 - 02/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2015 - 02/2012
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2006 - 10/2005
1	CreatinineIBA 01/2023
1	EnzymesIBA 01/2023
1	HomocysteineIBA 01/2023
1	apixabanIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 11/2021
1	ToothpastesIBA 12/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018
1	HDL CholesterolIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 06/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2013
1	A-factor (Streptomyces)IBA 12/2012
1	Biomarkers (Surrogate Marker)IBA 02/2012
1	Tyrosine Kinase InhibitorsIBA 02/2012
1	Decitabine FDA Link 02/2012
1	Proteins (Proteins, Gene)FDA Link 02/2012
1	C-Reactive ProteinIBA 06/2008
1	Estrogen Receptor betaIBA 01/2007
1	Lamotrigine (Lamictal)FDA LinkGeneric 12/2006
1	Retinaldehyde (Retinal)IBA 11/2006

Therapy/Procedure

3	Therapeutics 01/2018 - 01/2018
2	Length of Stay 11/2019 - 08/2014
2	Thrombectomy 01/2018 - 04/2013
2	Thrombolytic Therapy 10/2017 - 04/2014
1	Secondary Prevention 01/2018
1	Stents 04/2013
1	Aftercare (After-Treatment) 02/2012